Qube Research & Technologies (QRT)
VTVT icon

Qube Research & Technologies (QRT)’s vTv Therapeutics VTVT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,618
Closed -$223K – 4146
2026
Q1 		$223K Buy
+5,618
New +$204K ﹤0.01% 2929
2024
Q3 		– Sell
-1
Closed -$18 – 4182
2024
Q2 		$18 Buy
+1
New +$24 ﹤0.01% 3586

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VTVT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of vTv Therapeutics (VTVT) in Q2 2026, closing a stake of 5,618 shares — an estimated $223K sold.

Qube Research & Technologies (QRT) first reported a position in VTVT in Q2 2024 and held it in 2 quarters. The position peaked at $223K in Q1 2026. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining vTv Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,618 vTv Therapeutics shares in Q2 2026, an estimated $223K.
  • Qube Research & Technologies (QRT) first reported a position in vTv Therapeutics in Q2 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s vTv Therapeutics position peaked at $223K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.